PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 3.2

(-13.51%)

Gross Profit Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual gross profit in 2022 was 6.71 Million USD , down -39.32% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly gross profit in 2022 FY was 6.71 Million USD , down -39.32% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a annual gross profit of 11.06 Million USD in annual gross profit 2021, up 59.02% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a annual gross profit of 6.95 Million USD in annual gross profit 2020, up 11.16% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly gross profit of 11.06 Million USD for 2021 FY, up 59.02% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly gross profit of 6.95 Million USD for 2020 FY, up 11.16% from previous quarter.

Annual Gross Profit Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Gross Profit of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Gross Profit Gross Profit Growth
2022 6.71 Million USD -39.32%
2021 11.06 Million USD 59.02%
2020 6.95 Million USD 11.16%
2019 6.25 Million USD -17.49%
2018 7.58 Million USD -11.14%
2017 8.53 Million USD 8.89%
2016 7.83 Million USD 3.57%
2015 7.56 Million USD -1.38%
2014 7.67 Million USD -24.63%
2013 10.18 Million USD 23.97%
2012 8.21 Million USD 0.0%

Peer Gross Profit Comparison of PD-Rx Pharmaceuticals, Inc.

Name Gross Profit Gross Profit Difference
China Medicine Corporation 18.98 Million USD 64.639%
DH Enchantment Inc. -406.00 USD 1653556.158%
Exlites Holdings International, Inc. 18.74 Thousand USD -35721.942%
Itonis, Inc. 1801.00 USD -372639.145%
One Step Vending Corp. -1238.00 USD 542348.142%
MediPal Holdings Corporation 1.53 Billion USD 99.564%
Pharmagen, Inc. 3045.21 USD -220345.618%
Suzuken Co., Ltd. 1.22 Billion USD 99.452%